GlassScriptPhysician profile
Ian Atlas
NPI 1285634352
$1,437.35
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $601 · 2020: $145 · 2021: $405 · 2022: $286.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $365.90 | 2019-2021 | |
| Janssen Biotech, INC. | $272.96 | 2019-2021 | |
| Teleflex LLC | $75.03 | 2022 | |
| Coloplast Corp | $69.48 | 2019-2020 | |
| Intuitive Surgical, INC. | $62.83 | 2019 | |
| Pfizer INC. | $59.33 | 2019-2021 | |
| Antares Pharma, INC. | $56.99 | 2020-2021 | |
| Myovant Sciences INC. | $51.77 | 2021-2022 | |
| Tersera Therapeutics LLC | $51.48 | 2019 | |
| Dentsply Ih INC. | $43.85 | 2022 | |
| Abbvie INC. | $40.78 | 2022 | |
| Endo Pharmaceuticals INC. | $40.31 | 2021-2022 | |
| Integra Lifesciences Corporation | $33.33 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $30.35 | 2019 | |
| Urovant Sciences INC | $24.97 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $23.68 | 2019 | |
| 180 Medical, INC. | $23.49 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.79 | 2022 | |
| Allergan, INC. | $20.01 | 2021 | |
| Kci USA, INC. | $19.13 | 2022 | |
| Rochester Medical Corporation | $18.90 | 2022 | |
| Ucb, INC. | $17.21 | 2019 | |
| Cook Medical LLC | $14.78 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ian Atlas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.